Publications by authors named "David Chardin"

Claim this Profile
[
[F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal.
Mathilde Masse, David Chardin, Pierre Tricarico, Victoria Ferrari, Nicolas Martin

Eur J Nucl Med Mol Imaging· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total metabolic tumor volume on F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy.
Pierre Tricarico, David Chardin, Nicolas Martin, Sara Contu, Florent Hugonnet

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]-FDopa positron emission tomography imaging in corticobasal syndrome.
Anaïs El Ouartassi, Caroline Giordana, Aurélie Schiazza, David Chardin, Jacques Darcourt

Brain Imaging Behav· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: A prospective study.
Caroline Bailleux, Colette Zwarthoed, Ludovic Evesque, David Baron, Cyrielle Scouarnec, David Chardin

Radiother Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults.
David Chardin, Lun Jing, Mélanie Chazal-Ngo-Mai, Jean-Marie Guigonis, Valérie Rigau

Int J Mol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival analysis of patient groups defined by unsupervised machine learning clustering methods based on patient metabolomic data.
Caroline Bailleux, David Chardin, Jean-Marie Guigonis, Jean-Marc Ferrero, Yann Chateau

Comput Struct Biotechnol J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added value of [F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
Jacques Darcourt, David Chardin, Véronique Bourg, Jocelyn Gal, Renaud Schiappa

Eur J Nucl Med Mol Imaging· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic Signatures of Scarff-Bloom-Richardson (SBR) Grade in Non-Metastatic Breast Cancer.
Caroline Bailleux, David Chardin, Jocelyn Gal, Jean-Marie Guigonis, Sabine Lindenthal

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of immunotherapy-induced organ inflammation assessed on FDG PET in patients with metastatic non-small cell lung cancer.
Olivier Humbert, Matteo Bauckneht, Jocelyn Gal, Marie Paquet, David Chardin

Eur J Nucl Med Mol Imaging· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT.
Victor Comte, Hugo Schmutz, David Chardin, Fanny Orlhac, Jacques Darcourt

Eur J Nucl Med Mol Imaging· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning a confidence score and the latent space of a new supervised autoencoder for diagnosis and prognosis in clinical metabolomic studies.
David Chardin, Cyprien Gille, Thierry Pourcher, Olivier Humbert, Michel Barlaud

BMC Bioinformatics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection-an application in metabolomics studies.
David Chardin, Olivier Humbert, Caroline Bailleux, Fanny Burel-Vandenbos, Valerie Rigau

BMC Bioinformatics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer.
Estelle Mallet, Martina Aida Angeles, Bastien Cabarrou, David Chardin, Philippe Viau

Clin Nucl Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy.
Olivier Humbert, David Chardin

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study.
David Chardin, Marie Paquet, Renaud Schiappa, Jacques Darcourt, Caroline Bailleux

J Immunother Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer.
Jocelyn Gal, Caroline Bailleux, David Chardin, Thierry Pourcher, Julia Gilhodes

Comput Struct Biotechnol J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUV calculation in breast cancer: which normalization should be applied when using 18F-FDG PET?
Olivier Humbert, Jean-Marc Riedinger, David Chardin, Isabelle Desmoulins, François Brunotte

Q J Nucl Med Mol Imaging· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
Olivier Humbert, Véronique Bourg, Lydiane Mondot, Jocelyn Gal, Pierre-Yves Bondiau, David Chardin

Eur J Nucl Med Mol Imaging· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
Olivier Humbert, Véronique Bourg, Lydiane Mondot, Jocelyn Gal, Pierre-Yves Bondiau, David Chardin

Eur J Nucl Med Mol Imaging· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False positive 18FDG PET-CT results due to exogenous lipoid pneumonia secondary to oily drug inhalation: A case report.
David Chardin, Guillaume Nivaggioni, Philippe Viau, Caherine Butori, Bernard Padovani

Medicine (Baltimore)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis